Literature DB >> 25579351

Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.

Amedea B Seabra, Renata de Lima, Marcelo Calderón1.   

Abstract

Nitric oxide (NO) is known to have dichotomous effects on cancer biology, acting as a pro- or antineoplastic agent. Low concentrations of NO are reported to promote tumor growth, whereas high NO influx acts as a potent tumor repressor, leading to cytotoxicity and apoptosis. There is increasing interest in developing NO-releasing materials as potent tumoricidal agents in which high and localized concentrations of NO may be directly released in a sustained manner to the tumor site. Nanomaterials allied to NO donors have emerged as a promising strategy in cancer treatment. In this context, this review summarizes the roles of NO in cancer biology and highlights the therapeutic potential effects of NO-releasing nanomaterials based on polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles and quantum dots in combating tumor cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25579351     DOI: 10.2174/1568026615666150108122918

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  6 in total

Review 1.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

Review 2.  Computational Structural Biology of S-nitrosylation of Cancer Targets.

Authors:  Emmanuelle Bignon; Maria Francesca Allega; Marta Lucchetta; Matteo Tiberti; Elena Papaleo
Journal:  Front Oncol       Date:  2018-08-14       Impact factor: 6.244

Review 3.  The application of nitric oxide delivery in nanoparticle-based tumor targeting drug delivery and treatment.

Authors:  Lin Qin; Huile Gao
Journal:  Asian J Pharm Sci       Date:  2018-11-22       Impact factor: 6.598

Review 4.  Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO.

Authors:  Khosrow Kashfi; Jasmine Kannikal; Niharika Nath
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

Review 5.  Nitric Oxide-Releasing Platforms for Treating Cardiovascular Disease.

Authors:  Mingyue He; Deping Wang; Yumei Xu; Fangying Jiang; Jian Zheng; Yanlin Feng; Jimin Cao; Xin Zhou
Journal:  Pharmaceutics       Date:  2022-06-25       Impact factor: 6.525

Review 6.  The regulation of nitric oxide in tumor progression and therapy.

Authors:  Ya Hu; Jing Xiang; Linlin Su; Xi Tang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.